AA
AlphaCentric Advisors Portfolio holdings
AUM
$100M
This Quarter Return
+5.44%
1 Year Return
+18.84%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$180M
AUM Growth
+$180M
(+24%)
Cap. Flow
+$31.5M
Cap. Flow
% of AUM
17.49%
Top 10 Holdings %
Top 10 Hldgs %
21.59%
Holding
287
New
77
Increased
46
Reduced
73
Closed
55
Top Buys
| 1 |
Jazz Pharmaceuticals
JAZZ
|
$4.18M |
| 2 |
Invesco S&P 500 Pure Value ETF
RPV
|
$2.42M |
| 3 |
Coherus Oncology, Inc. Common Stock
CHRS
|
$2.38M |
| 4 |
iShares Russell 1000 Value ETF
IWD
|
$2.37M |
| 5 |
Amylyx Pharmaceuticals
AMLX
|
$2.17M |
Top Sells
| 1 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
$4.07M |
| 2 |
Invesco QQQ Trust
QQQ
|
$2.81M |
| 3 |
Invesco NASDAQ 100 ETF
QQQM
|
$2.81M |
| 4 |
Innoviva
INVA
|
$2.07M |
| 5 |
Bio-Rad Laboratories Class A
BIO
|
$1.63M |
Sector Composition
| 1 | Healthcare | 59.95% |
| 2 | Real Estate | 10.67% |
| 3 | Financials | 4.01% |
| 4 | Technology | 3.11% |
| 5 | Consumer Discretionary | 2.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
DX
26
Dynex Capital
DX
$1.64B
| $1.93M | 1.07% |
153,492
+34,902
| +29% | +$439K |
|
27
Lantheus
LNTH
$3.73B
| $1.93M | 1.07% |
23,000
| – | – |
|
28
Phathom Pharmaceuticals
PHAT
$864M
| $1.86M | 1.03% |
+130,000
| New | +$1.86M |
|
|
NYMT
29
New York Mortgage Trust
NYMT
$652M
| $1.84M | 1.02% |
185,963
+13,884
| +8% | +$138K |
|
|
TSVT
30
DELISTED
2seventy bio
TSVT
| $1.82M | 1.01% |
180,000
-122,500
| -40% | -$1.24M |
|
31
MGIC Investment
MTG
$6.42B
| $1.8M | 1% |
113,900
+60,000
| +111% | +$947K |
|
32
GSK
GSK
$79.9B
| $1.78M | 0.99% |
50,000
-30,000
| -38% | -$1.07M |
|
33
Procept Biorobotics
PRCT
$2.23B
| $1.77M | 0.98% |
50,000
| – | – |
|
34
Intuitive Surgical
ISRG
$170B
| $1.71M | 0.95% |
5,000
| – | – |
|
35
Ironwood Pharmaceuticals
IRWD
$214M
| $1.68M | 0.93% |
+157,500
| New | +$1.68M |
|
36
ADC Therapeutics
ADCT
$345M
| $1.67M | 0.93% |
778,000
+18,000
| +2% | +$38.7K |
|
37
Amicus Therapeutics
FOLD
$2.34B
| $1.66M | 0.92% |
+132,500
| New | +$1.66M |
|
|
ITCI
38
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $1.61M | 0.9% |
25,500
| – | – |
|
39
UroGen Pharma
URGN
$900M
| $1.58M | 0.88% |
+152,500
| New | +$1.58M |
|
40
Kiniksa Pharmaceuticals
KNSA
$2.48B
| $1.55M | 0.86% |
110,000
+27,500
| +33% | +$387K |
|
41
Karyopharm Therapeutics
KPTI
$61.7M
| $1.45M | 0.8% |
810,000
+570,000
| +238% | +$1.02M |
|
42
Fulgent Genetics
FLGT
$679M
| $1.44M | 0.8% |
39,000
-500
| -1% | -$18.5K |
|
|
PETQ
43
DELISTED
PetIQ, Inc. Class A Common Stock
PETQ
| $1.44M | 0.8% |
95,000
| – | – |
|
44
BioMarin Pharmaceuticals
BMRN
$11.2B
| $1.43M | 0.79% |
16,500
+11,000
| +200% | +$953K |
|
45
Dynavax Technologies
DVAX
$1.19B
| $1.42M | 0.79% |
110,000
+2,500
| +2% | +$32.3K |
|
|
MOR
46
DELISTED
MorphoSys AG American Depositary Shares
MOR
| $1.38M | 0.77% |
185,000
| – | – |
|
47
Accuray
ARAY
$157M
| $1.35M | 0.75% |
350,000
| – | – |
|
48
Ultragenyx Pharmaceutical
RARE
$2.89B
| $1.31M | 0.73% |
28,500
| – | – |
|
49
Day One Biopharmaceuticals
DAWN
$769M
| $1.31M | 0.73% |
+110,000
| New | +$1.31M |
|
50
AGNC Investment
AGNC
$10.2B
| $1.26M | 0.7% |
124,646
+31,900
| +34% | +$323K |
|